Literature DB >> 6624448

Secondary renal oxalosis. A statistical analysis of its possible causes.

S Mori, T Beppu.   

Abstract

Various clinical and pathologic items were examined regarding renal oxalosis in 501 autopsy cases. The rubeanic acid method (Yasue) was applied to 501 kidney sections to demonstrate the presence of calcium oxalate crystals. The extent of renal oxalosis was determined by counting the black-stained crystals per 10 low-power field (1.3 cm2). Thus, severe oxalosis (more than 50 crystals) was observed in 38 cases; moderate oxalosis (between 10 and 50 crystals) in 19 cases; mild (fewer than 10 crystals) in 36 cases, and no deposition in 408 cases. Acute or chronic renal failure and xylitol infusion were found to be highly correlated to renal oxalosis. Cases with diabetes mellitus, with hepatocellular degeneration, or with glucose infusion, as well as neoplasms or some other alleged causes, were found to be primarily unrelated to renal oxalosis, even though the overlapping renal insufficiency, or xylitol infusion caused some of these items to appear related. In cases with xylitol infusion, the extent of renal oxalosis was shown to be dose-dependent: No severe or moderate oxalosis was observed in cases where the total dose of infusion was less than 100 g, while in cases over 500 g, 10/24, or 44 percent, showed severe oxalosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6624448

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  6 in total

1.  Fatal cerebro-renal oxalosis after appendectomy.

Authors:  H Pfeiffer; F U Weiss; B Karger; A Aghdassi; M M Lerch; B Brinkmann
Journal:  Int J Legal Med       Date:  2003-11-22       Impact factor: 2.686

Review 2.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

Review 3.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

Review 4.  Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.

Authors:  Colin B Ligon; Laura K Hummers; Zsuzsanna H McMahan
Journal:  Semin Arthritis Rheum       Date:  2015-07-02       Impact factor: 5.532

Review 5.  Calcium oxalate crystal deposition in the kidney: identification, causes and consequences.

Authors:  R Geraghty; K Wood; J A Sayer
Journal:  Urolithiasis       Date:  2020-07-27       Impact factor: 3.436

6.  Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease.

Authors:  Theresa Ermer; Christoph Kopp; John R Asplin; Ignacio Granja; Mark A Perazella; Martin Reichel; Thomas D Nolin; Kai-Uwe Eckardt; Peter S Aronson; Fredric O Finkelstein; Felix Knauf
Journal:  Kidney Int Rep       Date:  2017-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.